Cancer Research
- Bristol-Myers Squibb Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) As A Treatment Option For Chronic Hepatitis B
-
Entecavir FAD, June 2008. For media enquiries contact: Caroline Almeida, Bristol-Myers Squibb, Tel: ...
Article - Anna Ohlden - Aug 29 2008 - 5:30am
- British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines
-
3, p48. Insulin Secretion Physiology. Elsevier Inc. 2004. For further information please contact ...
Article - Anna Ohlden - Aug 31 2008 - 6:33pm
- Merck Serono Completes Enrollment In The REFLEX Trial Of Rebif(R) In Patients At Risk Of Developing Multiple Sclerosis
-
by contacting the Company or visiting its website. Additional therapeutic options are currently under ...
Article - Anna Ohlden - Sep 17 2008 - 1:31am
- Bloodstream: New Route For Ovarian Cancer Spread
-
found. Ovarian cancer has been thought mainly to spread via direct surface contact with neighboring ...
Article - News Staff - Jul 14 2014 - 3:02pm
- Pancreatic Cancer May Be Spread By Survival Mechanism
-
cells become transformed but remain in direct contact with their normal neighbors? Working as ...
Article - The Conversation - Jan 22 2015 - 9:00am
- Does The HPV Vaccine Really Prevent Cervical Cancer?
-
Most people who have sexual contact at some point in their life will be exposed to HPV. In the majority ...
Article - News Staff - May 9 2018 - 3:28pm
- Oncolytics Biotech Inc. Reports Positive Interim Results Of U.K. Phase Ia/Ib Combination REOLYSIN(R) And Radiation Clinical Tria
-
This relationship enables close daily contact between research scientists and those on the frontline in ...
Article - Anna Ohlden - Sep 28 2007 - 3:04pm
- Oncolytics Biotech Inc. Reports Positive Interim Results Of U.K. Phase Ia/Ib Combination REOLYSIN(R) And Radiation Clinical Tria
-
This relationship enables close daily contact between research scientists and those on the frontline in ...
Article - Anna Ohlden - Oct 1 2007 - 1:29am
- Genzyme And Bayer Schering Pharma AG, Germany To Present New Data On Alemtuzumab In Multiple Sclerosis At ECTRIMS
-
the CARE-MS trials should contact Genzyme Medical Information at +1-800-745-4447, option 2 in the ...
Article - Anna Ohlden - Oct 11 2007 - 3:06pm
- Merck Serono Submits European Marketing Authorization Application For Sapropterin As A Treatment For Hyperphenylalaninemia
-
information, please visit http://www.merckserono.net or http://www.merck.de Contacts: Merck Serono, 9 Chemin ...
Article - Anna Ohlden - Nov 8 2007 - 2:48am

